Business
RushNet Inc. Cancellation of Proposed Reverse Split
RushNet Inc. Cancellation of Proposed Reverse Split.
About this update from Rushnet, Inc.
[{"type":"text","content":"ALPHARETTA, GA / ACCESSWIRE / June 9, 2021 / RushNet, Inc. (OTC PINK:RSHN) ("RushNet") with merger/acquisition target heliosDX, is pleased to announce the official cancelation of the proposed Reverse Split (RS). The company will file with the Colorado Secretary of State to reflect such cancelation.About HeliosDx:heliosDX is a National Independent Clinical Reference Laboratory offering High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. We are contracted in 44 of the lower 48 states and looking to expand our reach and capabilities. Always staying ahead of the curve, by continually investing in our infrastructure with the most efficient scientific proven instruments, and latest cutting-edge software for patient and physician satisfaction. This allows heliosDX to provide physicians fast and accurate reporting meeting and exceeding industry benchmarks. We excel in patient and client care through physician designed panels that aid in testing compliance and reporting education.Contact: Ashley [email protected] (Under Development)Twitter: @dx_heliosSafe Harbor NoticeCertain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). The Companies caution that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. The Companies undertake no obligation to revise these statements following the date of this news release.Investor caution/added risk for investors in companies claiming involvement in COVID-19 initiatives -On April 8, 2020, SEC Chairman Jay Clayton and William Hinman, the Director of the Division of Corporation Finance, issued a joint public statement on the importance of disclosure during the COVID-19 crisis.The SEC and Self-Regulatory Organizations are targeting public companies that claim to have products, treatment, or other str...